EP3046956A4 - Polymer films - Google Patents

Polymer films Download PDF

Info

Publication number: EP3046956A4
Authority: EP; European Patent Office
Prior art keywords: polymer films; films; polymer
Prior art date: 2013-09-19
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

EP14845609.8A

Other languages

German (de)

French (fr)

Other versions

EP3046956A1 (en

EP3046956B1 (en

Inventor

Gregory M. Cruise

Gloria Hincapie

Clayton Harris

Yue Wu

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

MicroVention Inc

Original Assignee

MicroVention Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-09-19

Filing date

2014-09-19

Publication date

2017-05-17

2014-09-19 Application filed by MicroVention Inc filed Critical MicroVention Inc

2016-07-27 Publication of EP3046956A1 publication Critical patent/EP3046956A1/en

2017-05-17 Publication of EP3046956A4 publication Critical patent/EP3046956A4/en

2019-08-28 Application granted granted Critical

2019-08-28 Publication of EP3046956B1 publication Critical patent/EP3046956B1/en

Status Active legal-status Critical Current

2034-09-19 Anticipated expiration legal-status Critical

Classifications

- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F222/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
- C08F222/10—Esters
- C08F222/1006—Esters of polyhydric alcohols or polyhydric phenols
- C08F222/102—Esters of polyhydric alcohols or polyhydric phenols of dialcohols, e.g. ethylene glycol di(meth)acrylate or 1,4-butanediol dimethacrylate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/048—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/148—Materials at least partially resorbable by the body
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F120/00—Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
- C08F120/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F120/52—Amides or imides
- C08F120/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
- C08F120/56—Acrylamide; Methacrylamide
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J5/00—Manufacture of articles or shaped materials containing macromolecular substances
- C08J5/18—Manufacture of films or sheets
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/0008—Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
- C08K5/0025—Crosslinking or vulcanising agents; including accelerators
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/04—Oxygen-containing compounds
- C08K5/05—Alcohols; Metal alcoholates
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/04—Oxygen-containing compounds
- C08K5/09—Carboxylic acids; Metal salts thereof; Anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
- A61L2300/604—Biodegradation
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2439/00—Containers; Receptacles
- B32B2439/80—Medical packaging
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B3/00—Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
- B65B3/003—Filling medical containers such as ampoules, vials, syringes or the like
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/52—Amides or imides
- C08F220/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
- C08F220/56—Acrylamide; Methacrylamide
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F222/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
- C08F222/36—Amides or imides
- C08F222/38—Amides
- C08F222/385—Monomers containing two or more (meth)acrylamide groups, e.g. N,N'-methylenebisacrylamide
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2333/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers
- C08J2333/04—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers esters
- C08J2333/14—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers esters of esters containing halogen, nitrogen, sulfur, or oxygen atoms in addition to the carboxy oxygen
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2333/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers
- C08J2333/24—Homopolymers or copolymers of amides or imides
- C08J2333/26—Homopolymers or copolymers of acrylamide or methacrylamide
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
- Y10T428/1334—Nonself-supporting tubular film or bag [e.g., pouch, envelope, packet, etc.]
- Y10T428/1341—Contains vapor or gas barrier, polymer derived from vinyl chloride or vinylidene chloride, or polymer containing a vinyl alcohol unit
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/21—Circular sheet or circular blank

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Polymers & Plastics (AREA)
Organic Chemistry (AREA)
Surgery (AREA)
Vascular Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Pharmacology & Pharmacy (AREA)
Biomedical Technology (AREA)
Manufacturing & Machinery (AREA)
Inorganic Chemistry (AREA)
Dermatology (AREA)
Neurosurgery (AREA)
Molecular Biology (AREA)
Materials Engineering (AREA)
Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Materials For Medical Uses (AREA)
Manufacture Of Macromolecular Shaped Articles (AREA)
Biological Depolymerization Polymers (AREA)
Medicinal Preparation (AREA)

EP14845609.8A 2013-09-19 2014-09-19 Polymer films Active EP3046956B1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201361880029P	2013-09-19	2013-09-19
PCT/US2014/056647 WO2015042462A1 (en)	2013-09-19	2014-09-19	Polymer films

Publications (3)

Publication Number	Publication Date
EP3046956A1 EP3046956A1 (en)	2016-07-27
EP3046956A4 true EP3046956A4 (en)	2017-05-17
EP3046956B1 EP3046956B1 (en)	2019-08-28

Family

ID=52668197

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP14845609.8A Active EP3046956B1 (en)	2013-09-19	2014-09-19	Polymer films

Country Status (9)

Country	Link
US (3)	US9408916B2 (en)
EP (1)	EP3046956B1 (en)
JP (2)	JP6641265B2 (en)
KR (2)	KR102340388B1 (en)
CN (1)	CN105555847B (en)
AU (1)	AU2014321278B2 (en)
BR (1)	BR112016005768B1 (en)
CA (1)	CA2923741C (en)
WO (1)	WO2015042462A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN110279885B (en)	2013-09-19	2022-07-26	泰尔茂株式会社	Polymer particles
CA2923741C (en)	2013-09-19	2022-06-07	Microvention, Inc.	Polymer films
KR102287781B1 (en)	2013-11-08	2021-08-06	테루모 가부시키가이샤	Polymer particles
US9265512B2 (en)	2013-12-23	2016-02-23	Silk Road Medical, Inc.	Transcarotid neurovascular catheter
ES2770321T3 (en)	2015-02-04	2020-07-01	Route 92 Medical Inc	Rapid Aspiration Thrombectomy System
US11020133B2 (en)	2017-01-10	2021-06-01	Route 92 Medical, Inc.	Aspiration catheter systems and methods of use
US11065019B1 (en)	2015-02-04	2021-07-20	Route 92 Medical, Inc.	Aspiration catheter systems and methods of use
US10799669B2 (en)	2017-01-20	2020-10-13	Route 92 Medical, Inc.	Single operator intracranial medical device delivery systems and methods of use
US9907880B2 (en)	2015-03-26	2018-03-06	Microvention, Inc.	Particles
WO2017019563A1 (en)	2015-07-24	2017-02-02	Route 92 Medical, Inc.	Anchoring delivery system and methods
JP7012655B2 (en)	2016-02-24	2022-01-28	インセプト、リミテッド、ライアビリティ、カンパニー	Flexible enhanced neurovascular catheter
KR102174285B1 (en)	2016-09-28	2020-11-05	테루모 가부시키가이샤	Polymer particles
KR101868113B1 (en) *	2016-12-19	2018-06-18	주식회사 인터코스	Manufacturing method of mask pack
JP7264581B2 (en)	2017-01-06	2023-04-25	インセプト、リミテッド、ライアビリティ、カンパニー	Antithrombotic coating for aneurysm treatment devices
CA3095844A1 (en)	2018-05-01	2019-11-07	Incept, Llc	Devices and methods for removing obstructive material from an intravascular site
US11395665B2 (en)	2018-05-01	2022-07-26	Incept, Llc	Devices and methods for removing obstructive material, from an intravascular site
US11607523B2 (en)	2018-05-17	2023-03-21	Route 92 Medical, Inc.	Aspiration catheter systems and methods of use
WO2020010310A1 (en)	2018-07-06	2020-01-09	Imperative Care, Inc.	Sealed neurovascular extendable catheter
US11471582B2 (en)	2018-07-06	2022-10-18	Incept, Llc	Vacuum transfer tool for extendable catheter
US11766539B2 (en)	2019-03-29	2023-09-26	Incept, Llc	Enhanced flexibility neurovascular catheter
CA3157362A1 (en)	2019-10-15	2021-04-22	Imperative Care, Inc.	Systems and methods for multivariate stroke detection
CN113365687A (en)	2019-12-18	2021-09-07	因普瑞缇夫护理公司	Method and system for treating venous thromboembolic disorders
US11553935B2 (en)	2019-12-18	2023-01-17	Imperative Care, Inc.	Sterile field clot capture module for use in thrombectomy system
US20210316127A1 (en)	2019-12-18	2021-10-14	Imperative Care, Inc.	Hemostasis valve
CN118925025A (en)	2020-03-10	2024-11-12	因普瑞缇夫护理公司	Neurovascular catheters with enhanced flexibility
US11207497B1 (en)	2020-08-11	2021-12-28	Imperative Care, Inc.	Catheter with enhanced tensile strength
US20220111177A1 (en)	2020-10-09	2022-04-14	Route 92 Medical, Inc.	Aspiration catheter systems and methods of use
US20230047098A1 (en)	2021-08-12	2023-02-16	Imperative Care, Inc.	Multi catheter method of performing a robotic neurovascular procedure

Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002015913A1 (en) *	2000-08-23	2002-02-28	Phairson Medical, Inc.	Treatment of trauma, and other indications
US20020071855A1 (en) *	2000-07-28	2002-06-13	Anika Therapeutics, Inc	Bioabsorbable composites of derivatized hyaluronic acid and other biodegradable, biocompatible polymers
US20060057098A1 (en) *	2004-09-15	2006-03-16	Seikagaku Corporation	Photoreactive polysaccharide, photocrosslinked polysaccharide product and method of making same and medical materials made from the crosslinked polysaccharide
WO2012133737A1 (en) *	2011-03-31	2012-10-04	公益財団法人地球環境産業技術研究機構	Crosslinkable amine compound, polymer membrane using crosslinkable amine compound, and method for producing polymer membrane

Family Cites Families (142)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4070348A (en)	1973-07-25	1978-01-24	Rohm Gmbh	Water-swellable, bead copolymer
US4157323A (en)	1976-06-09	1979-06-05	California Institute Of Technology	Metal containing polymeric functional microspheres
US6309669B1 (en)	1984-03-16	2001-10-30	The United States Of America As Represented By The Secretary Of The Army	Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix
FR2596399B1 (en)	1986-03-28	1988-09-02	Univ Rennes	NANOPARTICLES BASED ON METHACRYLIC POLYMER OR COPOLYMER, PREPARATION METHOD, AND APPLICATION AS MEDICAMENT VECTOR
US4925677A (en)	1988-08-31	1990-05-15	Theratech, Inc.	Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents
FR2676927B1 (en)	1991-05-29	1995-06-23	Ibf	MICROSPHERES FOR USE IN THERAPEUTIC VASCULAR OCCLUSIONS AND INJECTABLE SOLUTIONS CONTAINING THEM.
US5545423A (en)	1991-11-25	1996-08-13	Vivorx, Inc.	Cytoprotective, biocompatible, retrievable macrocapsule containment systems for biologically active materials
EP0627911B1 (en)	1992-02-28	2000-10-25	Board Of Regents The University Of Texas System	Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
JPH05279416A (en) *	1992-03-31	1993-10-26	Ajinomoto Co Inc	Hydrophilic biodegradable polymer
ATE183641T1 (en)	1992-12-23	1999-09-15	Saitec Srl	METHOD FOR PRODUCING MEDICINAL FORMS AND CONTROLLED RELEASE AND THE MEDICINAL FORMS OBTAINED
NO940115D0 (en)	1994-01-13	1994-01-13	Nycomed Imaging As	Contrast agents for X-ray and magnetic tomographic imaging
US5417982A (en)	1994-02-17	1995-05-23	Modi; Pankaj	Controlled release of drugs or hormones in biodegradable polymer microspheres
GB9406094D0 (en)	1994-03-28	1994-05-18	Univ Nottingham And University	Polymer microspheres and a method of production thereof
DE19543366C2 (en)	1995-11-21	1998-09-10	Stockhausen Chem Fab Gmbh	Water-swellable polymers crosslinked with unsaturated amino alcohols, their preparation and use
US5906997A (en)	1997-06-17	1999-05-25	Fzio Med, Inc.	Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions
US6048908A (en)	1997-06-27	2000-04-11	Biopore Corporation	Hydrophilic polymeric material
SE9704401D0 (en)	1997-11-28	1997-11-28	Astra Ab	Matrix pellets for greasy, oily or sticky drug substances
ATE283709T1 (en)	1998-03-06	2004-12-15	Biosepra Medical Inc	IMPLANTABLE PARTICLES TO INCREASE TISSUE VOLUME AND TREAT GASTROESOPHAGAL REFLUX, INCONTINENCE AND SKIN WRINKLES
US7662409B2 (en)	1998-09-25	2010-02-16	Gel-Del Technologies, Inc.	Protein matrix materials, devices and methods of making and using thereof
FR2784580B1 (en)	1998-10-16	2004-06-25	Biosepra Inc	POLYVINYL-ALCOHOL MICROSPHERES AND METHODS OF MAKING THE SAME
US8802146B2 (en)	1998-11-06	2014-08-12	Neomend, Inc.	Systems, methods, and compositions for prevention of tissue adhesion
US6248363B1 (en)	1999-11-23	2001-06-19	Lipocine, Inc.	Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
AU4564200A (en)	1999-04-29	2000-11-17	Aventis Pharma S.A.	Method for treating cancer using camptothecin derivatives and 5-fluorouracil
US6521431B1 (en)	1999-06-22	2003-02-18	Access Pharmaceuticals, Inc.	Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments
JP2003525682A (en)	2000-03-06	2003-09-02	シメッドライフシステムズインコーポレイテッド	Embolic agent visible under ultrasound
DE60115212T2 (en)	2000-03-13	2006-07-27	Biocure, Inc.	BIOMEDICAL ARTICLES FROM HYDROGEL
US6436424B1 (en)	2000-03-20	2002-08-20	Biosphere Medical, Inc.	Injectable and swellable microspheres for dermal augmentation
US8697137B2 (en)	2000-03-24	2014-04-15	Biosphere Medical, Inc.	Methods of using microspheres for active embolization
US7858119B1 (en)	2000-05-09	2010-12-28	Amina Odidi	Extended release pharmaceuticals
WO2002016443A1 (en) *	2000-08-23	2002-02-28	Phairson Medical Inc.	Novel polymer compounds
US6878384B2 (en) *	2001-03-13	2005-04-12	Microvention, Inc.	Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use
JP2004530676A (en)	2001-04-18	2004-10-07	ノストラム・ファーマスーティカルズ・インコーポレイテッド	Novel coatings for sustained release pharmaceutical compositions
US6685956B2 (en)	2001-05-16	2004-02-03	The Research Foundation At State University Of New York	Biodegradable and/or bioabsorbable fibrous articles and methods for using the articles for medical applications
DE60323936D1 (en)	2002-01-14	2008-11-20	Gen Hospital Corp	BIOABEAABLE POLYCETALES, METHOD FOR THE PRODUCTION THEREOF, AND THEIR USE
ES2285089T3 (en)	2002-01-28	2007-11-16	Coloplast A/S	EASY TO OPEN PACKING.
JP2003245544A (en)	2002-02-21	2003-09-02	Dainippon Ink & Chem Inc	Water absorbing material
US7462366B2 (en)	2002-03-29	2008-12-09	Boston Scientific Scimed, Inc.	Drug delivery particle
US7094369B2 (en)	2002-03-29	2006-08-22	Scimed Life Systems, Inc.	Processes for manufacturing polymeric microspheres
US7838699B2 (en)	2002-05-08	2010-11-23	Biosphere Medical	Embolization using degradable crosslinked hydrogels
CN101602847B (en)	2002-06-17	2013-03-20	日本电气株式会社	Biodegradable resin, biodegradable resin composition, biodegradable molded object, and process for producing biodegradable resin
GB2399084B (en)	2002-07-30	2007-01-31	Univ Liverpool	Porous beads and method of production thereof
EP1534351B1 (en)	2002-08-09	2006-10-04	Boston Scientific Limited	Embolization
US7842377B2 (en)	2003-08-08	2010-11-30	Boston Scientific Scimed, Inc.	Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US7449236B2 (en)	2002-08-09	2008-11-11	Boston Scientific Scimed, Inc.	Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US20060069168A1 (en)	2002-10-29	2006-03-30	Norikazu Tabata	Vascular embolization material
US7144588B2 (en)	2003-01-17	2006-12-05	Synovis Life Technologies, Inc.	Method of preventing surgical adhesions
EP1631375B1 (en)	2003-01-17	2011-11-02	Cornell Research Foundation, Inc.	Injectable hydrogel microspheres from aqueous two-phase system
US20040161466A1 (en)	2003-02-14	2004-08-19	Biocompatibles Uk Limited	Chemoembolisation
US7741421B2 (en)	2003-03-14	2010-06-22	Reqmed Company, Ltd.	Methods for producing macromolecule-identifying polymers
EP1651192A1 (en)	2003-08-06	2006-05-03	Nirmal Mulye	Pharmaceutical composition containing water soluble drug
US7192693B2 (en) *	2004-02-24	2007-03-20	University Of Washington	Methods for photopatterning hydrogels
US7736671B2 (en)	2004-03-02	2010-06-15	Boston Scientific Scimed, Inc.	Embolization
US20050267556A1 (en)	2004-05-28	2005-12-01	Allan Shuros	Drug eluting implants to prevent cardiac apoptosis
CN101052378A (en)	2004-09-07	2007-10-10	生物相容英国有限公司	Drug delivery from embolic agents
US8367099B2 (en)	2004-09-28	2013-02-05	Atrium Medical Corporation	Perforated fatty acid films
US7332159B2 (en)	2004-09-30	2008-02-19	Board Of Regents Of The University Of Nebraska	Method and composition for inhibiting reperfusion injury in the brain
US9114162B2 (en)	2004-10-25	2015-08-25	Celonova Biosciences, Inc.	Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same
US20210299056A9 (en)	2004-10-25	2021-09-30	Varian Medical Systems, Inc.	Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods
EP1804773B1 (en)	2004-10-25	2011-03-30	CeloNova BioSciences Germany GmbH	Loadable polyphosphazene-comprising particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
US9107850B2 (en)	2004-10-25	2015-08-18	Celonova Biosciences, Inc.	Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
CA2596283C (en)	2005-01-28	2011-11-01	Tepha, Inc.	Embolization using poly-4-hydroxybutyrate particles
US20060222596A1 (en)	2005-04-01	2006-10-05	Trivascular, Inc.	Non-degradable, low swelling, water soluble radiopaque hydrogel polymer
KR100618382B1 (en)	2005-05-03	2006-08-31	삼성전자주식회사	Method and apparatus for measuring nuclear magnetic resonance longitudinal relaxation time of blood
EP3085362B1 (en)	2005-05-09	2021-01-13	Biosphere Medical, S.A.	Compositions and methods using microspheres and non-ionic contrast agents
US8343546B2 (en)	2005-09-13	2013-01-01	Coating Place, Inc.	Ion exchange resin treated to control swelling
JP2009508991A (en) *	2005-09-15	2009-03-05	ユニバーシティオブユタリサーチファウンデーション	Polymer composition and methods for making and using the same
AU2007204617A1 (en) *	2006-01-12	2007-07-19	Massachusetts Institute Of Technology	Biodegradable elastomers
EP2368581B1 (en)	2006-01-30	2018-08-29	Biosphere Medical, Inc.	Porous intravascular embolization particles and related methods
WO2007090127A2 (en)	2006-01-30	2007-08-09	Surgica Corporation	Compressible intravascular embolization particles and related methods and delivery systems
EP1986610B1 (en)	2006-02-10	2018-04-11	Biocompatibles UK Limited	Loading of hydrophobic drugs into hydrophilic polymer delivery systems
EP1989248B1 (en)	2006-02-28	2016-10-05	Evonik Degussa GmbH	Biodegradable super-absorbent polymer composition with good absorption and retention properties
US8252339B2 (en)	2006-04-11	2012-08-28	Massachusetts Institute Of Technology	Medical treatment applications of swellable and deformable microspheres
US7794755B2 (en)	2006-04-11	2010-09-14	E.I. Du Pont De Nemours And Company	Process for preparation of swellable and deformable microspheres
US8062673B2 (en)	2006-04-11	2011-11-22	E I Du Pont De Nemours And Company	Process for embolization using swellable and deformable microspheres
US7838035B2 (en)	2006-04-11	2010-11-23	E. I. Du Pont De Nemours And Company	Microsphere powder of high density, swellable, deformable, durable occlusion-forming microspheres
KR100722607B1 (en)	2006-05-11	2007-05-28	주식회사 펩트론	Method for producing sustained-release microspheres with improved dispersibility and injection dose
EP2019691B1 (en)	2006-05-15	2020-08-12	Massachusetts Institute of Technology	Polymers for functional particles
FR2906253A1 (en)	2006-09-22	2008-03-28	Biosphere Medical Sa	NOVEL BIO-COMPATIBLE POLYMER MATERIALS, PROCESS FOR OBTAINING THEM AND USES THEREOF, IN PARTICULAR IN MEDICAL IMAGING BY MAGNETIC RESONANCE
WO2008057163A2 (en)	2006-10-09	2008-05-15	Carnegie Mellon University	Preparation of functional gel particles with a dual crosslink network
GB0620504D0 (en)	2006-10-16	2006-11-22	Queen Mary & Westfield College	Method
CN101678041A (en) *	2007-03-30	2010-03-24	梅迪沃什有限公司	Bioabsorbable elastomeric polymer networks, cross-linkers and methods of use
EP1985286A1 (en)	2007-04-24	2008-10-29	Biocompatibles UK Limited	Microspheres for treatment of brain tumours
EP2143446B1 (en)	2007-05-01	2019-07-24	National University Corporation Tokyo Medical and Dental University	Hybrid gel comprising chemically crosslinked hyaluronic acid derivative and pharmaceutical composition comprising the same
KR100899147B1 (en)	2007-05-04	2009-05-27	한양대학교 산학협력단	Meta data storage method and metadata storage system
US8492334B2 (en)	2007-06-21	2013-07-23	Yale University	Sustained intraocular delivery of drugs from biodegradable polymeric microparticles
US8110226B2 (en)	2007-07-20	2012-02-07	Mylan Pharmaceuticals Inc.	Drug formulations having inert sealed cores
WO2009015281A2 (en)	2007-07-25	2009-01-29	Basf Corporation	Epoxy and hydroxy-functional acrylic resins for use in coating applications
US8815273B2 (en)	2007-07-27	2014-08-26	Boston Scientific Scimed, Inc.	Drug eluting medical devices having porous layers
US7887846B2 (en)	2007-08-07	2011-02-15	E. I. Du Pont De Nemours And Company	Process for preparation of swellable and degradable microspheres
GB0717516D0 (en)	2007-09-07	2007-10-17	Imp Innovations Ltd	Bioactive nanocomposite material
WO2009040434A1 (en)	2007-09-26	2009-04-02	Dsm Ip Assets B.V.	Microparticle comprising cross-linked polymer
US9107828B2 (en)	2007-10-05	2015-08-18	Boston Scientific Scimed, Inc.	Multi-component particles for injection and processes for forming the same
US8246998B2 (en)	2007-11-01	2012-08-21	Boston Scientific Scimed, Inc.	Injectable biodegradable particles
WO2009073193A2 (en)	2007-12-03	2009-06-11	The Johns Hopkins University	Methods of synthesis and use of chemospheres
BRPI0821070B1 (en)	2007-12-21	2018-10-23	Microvention Inc	implantation device and method for preparing a hydrogel filament for implantation in an animal
US20110033608A1 (en)	2008-03-06	2011-02-10	E.I. Du Pont De Nemours And Company	Process for making coated, water-swellable hydrogel microspheres
US20110009520A1 (en)	2008-03-20	2011-01-13	Figuly Garret D	Dimensionally stable, shaped articles comprised of dried, aggregated, water-swellable hydrogel microspheres and method of making same
US8114436B2 (en)	2008-03-25	2012-02-14	Boston Scientific Scimed, Inc.	Compositions and methods for delivery of embolics
ES2718477T3 (en)	2008-03-28	2019-07-02	Biotage Ab	Composite material
BRPI0907314B1 (en)	2008-04-21	2019-04-24	Nalco Company	Composition of expandable polymeric microparticle and method for modifying water permeability of an underground formation
EP2265262A1 (en)	2008-04-25	2010-12-29	DSM IP Assets B.V.	Particles comprising polymers with thioester bonds
US8557288B2 (en)	2008-08-15	2013-10-15	Washington University	Hydrogel microparticle formation in aqueous solvent for biomedical applications
US8739978B2 (en)	2008-08-20	2014-06-03	Kolon Industries Inc.	Porous membrane and preparation method thereof
CN102143996A (en)	2008-10-30	2011-08-03	大卫·刘	Micro-spherical porous biocompatible scaffolds and methods and apparatus for fabricating same
EP2367535B1 (en)	2008-12-02	2017-02-22	Biocompatibles Uk Ltd.	Pancreatic tumour treatment
BRPI0922385B1 (en) *	2008-12-16	2019-06-18	Carlsberg A/S	METHOD FOR COATING OF HYDROXYLATED SURFACES BY GAS PHASE ENZYME, MATERIAL WITH COATED SURFACE AND ITEM
JP2012100680A (en)	2009-03-04	2012-05-31	Terumo Corp	Treatment instrument to be used in blood vessel
JP2010227172A (en)	2009-03-26	2010-10-14	Terumo Corp	Material for soft tissue enlargement
US8481067B2 (en)	2009-06-04	2013-07-09	Clemson University Research Foundation	Methods for promoting the revascularization and reenervation of CNS lesions
WO2011014722A2 (en)	2009-07-30	2011-02-03	Cook Incorporated	Erodible embolization material
US20110033548A1 (en)	2009-08-05	2011-02-10	E.I. Du Pont De Nemours And Company	Degradable crosslinked aminated dextran microspheres and methods of use
US20110038936A1 (en)	2009-08-17	2011-02-17	Kimberly Ann Griswold	System and method for electrospun drug loaded biodegradable chemotherapy applications
EP2295480A1 (en) *	2009-09-10	2011-03-16	Occlugel	Implantable bio-resorbable polymer
EP2803370B1 (en)	2009-10-06	2019-02-27	Regents of the University of Minnesota	Bioresorbable embolization microspheres
BR112012012997B8 (en)	2009-12-04	2021-05-25	Magle Ab	Biodegradable microsphere, material for use in connection with wound treatment comprising microspheres, wound dressing and method for in vitro cell culture
US8366661B2 (en)	2009-12-18	2013-02-05	Boston Scientific Scimed, Inc.	Medical device with expandable body for drug delivery by capsules
EP2351779B1 (en)	2010-01-27	2019-04-24	Biosphere Medical, Inc.	Microspheres and method of making the microspheres
CN104958763A (en)	2010-02-22	2015-10-07	优势医疗公司	Methods and compositions for treating hemorrhagic conditions of the brain
JP2011201031A (en)	2010-03-24	2011-10-13	Dic Corp	Polymer substrate having laminated structure and medical appliance using the same
JP2011245267A (en)	2010-04-27	2011-12-08	Dic Corp	Sulfated polysaccharide immobilized porous polymeric base material and medical instrument
US8772355B2 (en)	2010-11-23	2014-07-08	Howard University	Stealth polymeric particles for delivery of bioactive or diagnostic agents
WO2012073188A1 (en)	2010-11-29	2012-06-07	Centre Hospitalier Universitaire Vaudois	Chemoembolization composition comprising anti-angiogenic agents
JP2012170773A (en)	2011-02-24	2012-09-10	Hamamatsu Univ School Of Medicine	Saccharide-immobilizing polymer base material obtained by using controlled radical polymerization, and medical instrument
EP2682140A4 (en)	2011-03-04	2014-07-30	Dainippon Ink & Chemicals	SUGAR POLYMER SUBSTRATE IMMOBILIZED TO ELIMINATE VIRUSES, AND METHOD OF REMOVING VIRUSES
EP2683750B1 (en)	2011-03-09	2017-04-19	Occlugel	Implantable swellable bio-resorbable polymer
JP2012187308A (en)	2011-03-11	2012-10-04	Hamamatsu Univ School Of Medicine	Sulfated polysaccharide immobilizing base material and method for removing virus using the same
US9456823B2 (en)	2011-04-18	2016-10-04	Terumo Corporation	Embolic devices
WO2012145739A1 (en) *	2011-04-21	2012-10-26	Trustees Of Tufts College	Compositions and methods for stabilization of active agents
CA2837087A1 (en) *	2011-05-27	2012-12-06	The University Of Akron	Peptide crosslinked bioactive polymeric materials
WO2013130143A2 (en)	2011-12-01	2013-09-06	The Regents Of The University Of California	Polaniline based membranes for separation of carbon dioxide and methane
WO2013177364A1 (en)	2012-05-24	2013-11-28	Biosphere Medical, Inc.	Biomaterials suitable for use as drug eluting, magnetic resonance imaging detectable implants for vascular occlusion
CA2866330A1 (en)	2012-05-30	2013-12-05	Boston Scientific Scimed, Inc.	Injectable biodegradable particles for controlled therapeutic agent release
WO2014034787A1 (en)	2012-08-31	2014-03-06	Dic株式会社	Dialyzer capable of removing viruses
TWI519339B (en)	2012-12-28	2016-02-01	財團法人工業技術研究院	Filtering membrane
JP6031405B2 (en)	2013-05-01	2016-11-24	株式会社Adeka	Benzotriazole compounds
CA2923741C (en)	2013-09-19	2022-06-07	Microvention, Inc.	Polymer films
CN110279885B (en)	2013-09-19	2022-07-26	泰尔茂株式会社	Polymer particles
KR102287781B1 (en)	2013-11-08	2021-08-06	테루모 가부시키가이샤	Polymer particles
CN103709323A (en)	2013-12-04	2014-04-09	天津工业大学	Hepatic targeted temperature sensitive microsphere and preparation method therefor
EP3137124B1 (en)	2014-04-29	2019-01-09	Microvention, Inc.	Polymers including active agents
US9907880B2 (en)	2015-03-26	2018-03-06	Microvention, Inc.	Particles
KR102174285B1 (en)	2016-09-28	2020-11-05	테루모 가부시키가이샤	Polymer particles

2014
- 2014-09-19 CA CA2923741A patent/CA2923741C/en active Active
- 2014-09-19 EP EP14845609.8A patent/EP3046956B1/en active Active
- 2014-09-19 WO PCT/US2014/056647 patent/WO2015042462A1/en active Application Filing
- 2014-09-19 KR KR1020167007854A patent/KR102340388B1/en active Active
- 2014-09-19 KR KR1020217040855A patent/KR102505172B1/en active Active
- 2014-09-19 AU AU2014321278A patent/AU2014321278B2/en active Active
- 2014-09-19 CN CN201480051681.2A patent/CN105555847B/en active Active
- 2014-09-19 US US14/491,813 patent/US9408916B2/en active Active
- 2014-09-19 JP JP2016515393A patent/JP6641265B2/en active Active
- 2014-09-19 BR BR112016005768-6A patent/BR112016005768B1/en active IP Right Grant
2016
- 2016-06-30 US US15/199,633 patent/US10227463B2/en active Active
2019
- 2019-01-25 US US16/258,313 patent/US11104772B2/en active Active
- 2019-12-27 JP JP2019238182A patent/JP2020097740A/en active Pending

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020071855A1 (en) *	2000-07-28	2002-06-13	Anika Therapeutics, Inc	Bioabsorbable composites of derivatized hyaluronic acid and other biodegradable, biocompatible polymers
WO2002015913A1 (en) *	2000-08-23	2002-02-28	Phairson Medical, Inc.	Treatment of trauma, and other indications
US20060057098A1 (en) *	2004-09-15	2006-03-16	Seikagaku Corporation	Photoreactive polysaccharide, photocrosslinked polysaccharide product and method of making same and medical materials made from the crosslinked polysaccharide
WO2012133737A1 (en) *	2011-03-31	2012-10-04	公益財団法人地球環境産業技術研究機構	Crosslinkable amine compound, polymer membrane using crosslinkable amine compound, and method for producing polymer membrane

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2015042462A1 *

Also Published As

Publication number	Publication date
US11104772B2 (en)	2021-08-31
US20190194406A1 (en)	2019-06-27
JP2020097740A (en)	2020-06-25
KR102340388B1 (en)	2021-12-17
CN105555847A (en)	2016-05-04
EP3046956A1 (en)	2016-07-27
KR20210156300A (en)	2021-12-24
WO2015042462A1 (en)	2015-03-26
JP6641265B2 (en)	2020-02-05
BR112016005768B1 (en)	2021-09-21
KR102505172B1 (en)	2023-02-28
CN105555847B (en)	2018-08-10
CA2923741A1 (en)	2015-03-26
AU2014321278A1 (en)	2016-03-17
US20160311990A1 (en)	2016-10-27
US9408916B2 (en)	2016-08-09
KR20160060051A (en)	2016-05-27
JP2016531955A (en)	2016-10-13
EP3046956B1 (en)	2019-08-28
CA2923741C (en)	2022-06-07
BR112016005768A2 (en)	2017-11-21
US10227463B2 (en)	2019-03-12
US20150079328A1 (en)	2015-03-19
AU2014321278B2 (en)	2016-11-10

Publication	Publication Date	Title
EP3046956A4 (en)	2017-05-17	Polymer films
EP3046952A4 (en)	2017-05-10	Polymer particles
EP3065719A4 (en)	2017-08-09	Polymer particles
EP2964572A4 (en)	2017-03-08	Graphene-based films
EP3071517A4 (en)	2017-05-24	Nanocellulose
EP3078690A4 (en)	2017-08-16	Block copolymer
EP3078689A4 (en)	2017-12-13	Block copolymer
EP3078687A4 (en)	2017-08-16	Block copolymer
EP3019710A4 (en)	2017-05-10	Plated polymer fan
EP3042928A4 (en)	2017-07-12	Plastic film
EP3101043A4 (en)	2017-12-06	Block copolymer
EP3078691A4 (en)	2017-07-05	Block copolymer
EP3065209A4 (en)	2017-06-21	Polymer electrolyte film
EP3078694A4 (en)	2017-08-09	Block copolymer
EP3039046A4 (en)	2017-05-03	Polyanionic polymers
EP3078692A4 (en)	2017-12-20	Block copolymer
EP3078685A4 (en)	2017-09-13	Block copolymer
EP3078688A4 (en)	2017-07-26	Block copolymer
EP3078695A4 (en)	2017-07-12	Block copolymer
EP3078686A4 (en)	2017-07-05	Block copolymer
EP3078693A4 (en)	2017-11-29	Block copolymer
EP3081317A4 (en)	2017-08-09	Molding device
EP3040200A4 (en)	2017-01-18	Plastic film laminate
HK1216155A1 (en)	2016-10-21	Jellyfish-derived polymer
EP3030603B8 (en)	2022-02-23	Polymeric materials

Legal Events

Date	Code	Title	Description
2016-06-24	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2016-07-27	17P	Request for examination filed	Effective date: 20160415
2016-07-27	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2016-07-27	AX	Request for extension of the european patent	Extension state: BA ME
2016-12-28	DAX	Request for extension of the european patent (deleted)
2017-05-17	A4	Supplementary search report drawn up and despatched	Effective date: 20170419
2017-05-17	RIC1	Information provided on ipc code assigned before grant	Ipc: A61L 31/04 20060101ALI20170411BHEP Ipc: C08L 101/16 20060101ALI20170411BHEP Ipc: C08F 220/52 20060101ALI20170411BHEP Ipc: C08G 75/00 20060101ALI20170411BHEP Ipc: A61L 31/16 20060101ALI20170411BHEP Ipc: C08F 222/38 20060101ALI20170411BHEP Ipc: C08F 220/26 20060101ALI20170411BHEP Ipc: C08J 5/18 20060101AFI20170411BHEP Ipc: C08F 290/00 20060101ALI20170411BHEP Ipc: C08F 220/56 20060101ALI20170411BHEP Ipc: C08G 63/91 20060101ALI20170411BHEP Ipc: A61K 9/00 20060101ALI20170411BHEP Ipc: A61L 31/14 20060101ALI20170411BHEP Ipc: C08F 220/38 20060101ALI20170411BHEP Ipc: C08F 120/56 20060101ALI20170411BHEP Ipc: C08F 222/10 20060101ALI20170411BHEP Ipc: C08G 69/48 20060101ALI20170411BHEP Ipc: A61K 47/32 20060101ALI20170411BHEP
2019-04-01	GRAP	Despatch of communication of intention to grant a patent	Free format text: ORIGINAL CODE: EPIDOSNIGR1
2019-04-01	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: GRANT OF PATENT IS INTENDED
2019-05-01	INTG	Intention to grant announced	Effective date: 20190402
2019-07-11	GRAJ	Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted	Free format text: ORIGINAL CODE: EPIDOSDIGR1
2019-07-11	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE
2019-07-19	GRAJ	Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted	Free format text: ORIGINAL CODE: EPIDOSDIGR1
2019-07-19	GRAL	Information related to payment of fee for publishing/printing deleted	Free format text: ORIGINAL CODE: EPIDOSDIGR3
2019-07-19	GRAR	Information related to intention to grant a patent recorded	Free format text: ORIGINAL CODE: EPIDOSNIGR71
2019-07-19	GRAS	Grant fee paid	Free format text: ORIGINAL CODE: EPIDOSNIGR3
2019-07-19	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: GRANT OF PATENT IS INTENDED
2019-07-26	GRAA	(expected) grant	Free format text: ORIGINAL CODE: 0009210
2019-07-26	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE PATENT HAS BEEN GRANTED
2019-08-14	INTC	Intention to grant announced (deleted)
2019-08-28	AK	Designated contracting states	Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2019-08-28	INTG	Intention to grant announced	Effective date: 20190719
2019-08-28	REG	Reference to a national code	Ref country code: GB Ref legal event code: FG4D
2019-08-30	REG	Reference to a national code	Ref country code: CH Ref legal event code: EP
2019-09-15	REG	Reference to a national code	Ref country code: AT Ref legal event code: REF Ref document number: 1172328 Country of ref document: AT Kind code of ref document: T Effective date: 20190915
2019-09-18	REG	Reference to a national code	Ref country code: IE Ref legal event code: FG4D
2019-09-19	REG	Reference to a national code	Ref country code: DE Ref legal event code: R096 Ref document number: 602014052704 Country of ref document: DE
2020-01-01	REG	Reference to a national code	Ref country code: NL Ref legal event code: MP Effective date: 20190828
2020-01-10	REG	Reference to a national code	Ref country code: LT Ref legal event code: MG4D
2020-01-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190828 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190828 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191230 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191128 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190828 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190828 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191128 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190828
2020-02-28	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191228 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190828 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191129 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190828 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190828 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190828
2020-03-15	REG	Reference to a national code	Ref country code: AT Ref legal event code: MK05 Ref document number: 1172328 Country of ref document: AT Kind code of ref document: T Effective date: 20190828
2020-03-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190828
2020-05-01	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190828 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190828 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190828 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190828 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190828 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190828
2020-05-29	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200224 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190828 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190828 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190828 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190828
2020-05-29	REG	Reference to a national code	Ref country code: CH Ref legal event code: PL
2020-06-03	REG	Reference to a national code	Ref country code: DE Ref legal event code: R097 Ref document number: 602014052704 Country of ref document: DE
2020-07-10	PLBE	No opposition filed within time limit	Free format text: ORIGINAL CODE: 0009261
2020-07-10	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT
2020-07-30	PG2D	Information on lapse in contracting state deleted	Ref country code: IS
2020-07-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190930 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190919 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190919 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190930
2020-08-06	REG	Reference to a national code	Ref country code: BE Ref legal event code: MM Effective date: 20190930
2020-08-12	26N	No opposition filed	Effective date: 20200603
2020-08-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190828 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190930
2021-05-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190828
2021-07-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190828 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20140919
2022-06-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190828
2023-07-12	P01	Opt-out of the competence of the unified patent court (upc) registered	Effective date: 20230529
2024-10-10	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: DE Payment date: 20240702 Year of fee payment: 11
2024-10-14	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: GB Payment date: 20240701 Year of fee payment: 11
2024-10-16	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: FR Payment date: 20240702 Year of fee payment: 11